Like this podcast? Create your own with Apisod

Unilever Faces CMA Remedy Deadline episode cover art
Nov 15, 2026 • 6 min
Covers news from Nov 8, 2026 to Nov 15, 2026

Unilever Faces CMA Remedy Deadline

Unilever Strategic Shifts podcast cover art
Unilever Strategic Shifts

Show Notes

UK regulators just threw a wrench into Unilever’s planned tie-up with McCormick, demanding fixes to preserve competition in the dry mixes and sauces aisle. The Competition and Markets Authority wants either Unilever’s legacy Colman’s or McCormick’s Schwartz assets on the block—each option carving up brand power and market share in a key European stronghold. If no remedy is agreed by November 18, the deal moves to an in-depth probe, threatening delays, higher costs, and a messier integration. For both consumer giants, what’s at stake isn’t just shelf space, but also the financial logic behind a cross-border merger that already cleared US regulators.

But here’s the complication: Unilever is also in the midst of a sweeping cost-cutting program, aiming for $1.12 billion in savings by 2029. The company is moving out of Myanmar, trimming geopolitical exposure, but the process drags through 2027—leaving loose ends just as management tries to prove it can actually deliver the promised savings and margin gains. With investors eyeing every move, the next few weeks will reveal whether Unilever and McCormick can seal the UK fix quietly, or if this deal turns into a regulatory marathon.

Based on reporting and insights from BeautyMatter and Cleveland.com.

Powered by Apisod.com